Female surgeons at a large academic medical center perform less complex surgical procedures than their male counterparts, according to a new study by researchers at Massachusetts General Hospital (MGH). This study, published in Annals of Surgery, is one of the first to measure the problem of underemployment among female surgeons in the United States, which can affect compensation, career advancement and job satisfaction.
Only about one in five surgeons practicing in U.S. is female. Unemployment is virtually nonexistent among surgeons, but many female surgeons, as well as professional women in other fields, experience underemployment — the underuse of skills — according to the Federal Reserve Bank. “Women in surgery talk among themselves about how they may be perceived as less confident or competent, and for those reasons they may have less opportunity to do exciting and challenging cases,” says Cassandra Kelleher, MD, a pediatric surgeon at MGH and senior
Surgical patients who participate in virtual follow-up visits after their operations spend a similar amount of time with surgical team members as those who meet face-to-face. Moreover, these patients benefit by spending less time waiting at and traveling to the clinic for in-person appointments, according to research findings presented at the virtual American College of Surgeons Clinical Congress 2020.
“I think it’s really valuable for patients to understand that, in the virtual space scenario, they are still going to get quality time with their surgical team,” said lead study author Caroline Reinke, MD, FACS, associate professor of surgery at Atrium Health in Charlotte, N.C. “A virtual appointment does not shorten that time, and there is still an ability to answer questions, connect, and address ongoing medical care.”
Due to the Coronavirus Disease 2019 (COVID-19) pandemic and the widespread adoption of technology, many surgical patients are being offered virtual appointments in
‘Junk Science’ and Roundup Verdicts Examined in the Journal of American Physicians and Surgeons
TUCSON, Ariz., Sept. 21, 2020
TUCSON, Ariz., Sept. 21, 2020 /PRNewswire/ — San Francisco juries have awarded up to $1 billion to persons claiming their cancer resulted from exposure to glyphosate, the active ingredient in the weedkiller Roundup™. In the fall issue of the Journal of American Physicians and Surgeons, Paul Driessen, J.D., examines the evidence and the legal process in this case study of litigation that is destroying companies and technology.
Law firms are still soliciting clients for lawsuits in which cumulative awards could reach trillions of dollars, Driessen writes.
Introduced in 1974, glyphosate is the world’s most widely used herbicide, he notes. Millions of homeowners, gardeners, and farmers use it regularly to kill weeds. Countless farmers employ it with “Roundup-Ready” corn, soybeans, cotton, and